BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9068128)

  • 1. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions.
    Frohna PA; Neal-Beliveau BS; Joyce JN
    Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neonatal 6-OHDA lesions upregulate adult expression of tyrosine hydroxylase mRNA.
    Frohna PA; Neal-Beliveau BS; Joyce JN
    Neuroreport; 1993 Sep; 4(9):1095-8. PubMed ID: 8106005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced glutamatergic phenotype of mesencephalic dopamine neurons after neonatal 6-hydroxydopamine lesion.
    Dal Bo G; Bérubé-Carrière N; Mendez JA; Leo D; Riad M; Descarries L; Lévesque D; Trudeau LE
    Neuroscience; 2008 Sep; 156(1):59-70. PubMed ID: 18706980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
    Szot P; White SS; Veith RC; Rasmussen DD
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C; Nikkhah G; Cunningham MG; Björklund A
    Exp Neurol; 1999 Sep; 159(1):177-90. PubMed ID: 10486186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neonatal 6-OHDA lesions differentially affect striatal D1 and D2 receptors.
    Neal BS; Joyce JN
    Synapse; 1992 May; 11(1):35-46. PubMed ID: 1351321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dual dopamine-glutamate phenotype of growing mesencephalic neurons regresses in mature rat brain.
    Bérubé-Carrière N; Riad M; Dal Bo G; Lévesque D; Trudeau LE; Descarries L
    J Comp Neurol; 2009 Dec; 517(6):873-91. PubMed ID: 19844994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
    Murer MG; Dziewczapolski G; Menalled LB; García MC; Agid Y; Gershanik O; Raisman-Vozari R
    Ann Neurol; 1998 May; 43(5):561-75. PubMed ID: 9585350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-injurious behavior and dopaminergic neuron system in neonatal 6-hydroxydopamine-lesioned rat: 1. Dopaminergic neurons and receptors.
    Yokoyama C; Okamura H
    J Pharmacol Exp Ther; 1997 Feb; 280(2):1016-30. PubMed ID: 9023319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
    Haber SN; Ryoo H; Cox C; Lu W
    J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of perinatal asphyxia on tyrosine hydroxylase and D2 and D1 dopamine receptor mRNA levels expressed during early postnatal development in rat brain.
    Gross J; Andersson K; Chen Y; Müller I; Andreeva N; Herrera-Marschitz M
    Brain Res Mol Brain Res; 2005 Apr; 134(2):275-81. PubMed ID: 15836923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
    Rothblat DS; Schroeder JA; Schneider JS
    J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
    Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
    Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
    Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
    Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
    Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
    J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon.
    Blanchard V; Raisman-Vozari R; Vyas S; Michel PP; Javoy-Agid F; Uhl G; Agid Y
    Brain Res Mol Brain Res; 1994 Mar; 22(1-4):29-38. PubMed ID: 7912404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. There is a limited critical period for dopamine's effects on D1 receptor expression in the developing rat neostriatum.
    Thomas WS; Neal-Beliveau BS; Joyce JN
    Brain Res Dev Brain Res; 1998 Nov; 111(1):99-106. PubMed ID: 9804909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
    González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
    J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.